Biotech/Biomedical
News Category

Quantum BioPharma Taps Thermo Fisher to Execute Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective MS Approach
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS, a first...

VERAXA Biotech Adopts FDA-Aligned New Approach Methodologies to Cut Animal Testing in Cancer Drug Development
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies (NAMs) to reduce animal testing in preclinical research, potentia...

SS Innovations Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
SS Innovations International (NASDAQ: SSII) is advancing telerobotic surgery with its SSi Mantra system, reporting 195 telesurgeries and a 45% increas...

Lantern Pharma Advances Phase 2 HARMONIC Trial with Taiwan Approvals, Targeting EGFR L858R Mutation in NSCLC
Lantern Pharma receives regulatory and IRB approvals in Taiwan to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially improving outcomes ...

Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective Approach
Quantum BioPharma's agreement with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS marks a significant step toward a ...

VERAXA Biotech Advances FDA-Aligned Methods to Cut Animal Testing in Cancer Drug Development
VERAXA Biotech's new approach methodologies could drastically reduce animal testing in preclinical cancer research, potentially accelerating drug deve...

Quantum BioPharma Partners with Thermo Fisher to Launch Phase 2 Lucid-MS Trial, Targeting Unmet Need in Progressive MS
Quantum BioPharma signs a Study Start-Up Agreement with Thermo Fisher's clinical research business to initiate a Phase 2 trial of Lucid-MS, a novel ne...

XORTX Therapeutics Advances XORLO Toward FDA New Drug Application as Gout Prevalence Projected to Surge
XORTX Therapeutics is advancing its gout treatment XORLO through manufacturing and regulatory milestones, targeting an FDA new drug application in abo...

National C60 Day Highlights the Growing Importance of Carbon 60 Research and Consumer Education
C60 Power's National C60 Day on October 9 promotes education and consumer awareness about carbon 60, a molecule with potential applications in wellnes...

C60 Power Marks National C60 Day, Spotlighting Fullerene Science and Wellness
C60 Power's National C60 Day on October 9 highlights the 1996 Nobel Prize in Chemistry for fullerenes and the growing consumer interest in Carbon 60 w...

Gold Recovery Gains Traction as Treasury Yields Drop and Rate Fears Ease
Gold prices extended their recovery on bargain buying, a weaker dollar, and falling Treasury yields, with softer U.S. economic data reducing the likel...

Skull's Hidden Lymphatic Role Could Reshape Brain Disease Treatment
A new study reveals lymph-node-like structures in the skull's bone marrow, suggesting a local immune defense for the brain that could lead to innovati...

In Vitro ADME Studies Streamline Drug Development and Reduce Costs
In vitro ADME studies are critical for early evaluation of drug candidates, helping to avoid costly late-stage failures and accelerate the drug develo...

Heart-Brain Protection Pioneer Jennifer S. Lawton to Receive 2026 AHA Basic Research Prize
The American Heart Association will honor Dr. Jennifer S. Lawton with its 2026 Basic Research Prize for her groundbreaking translational research in m...

Single-Dose MVA-X Vaccine Shows Durable Protection Against Clade I Mpox in Preclinical Models
GeoVax's next-generation MVA-X vaccine demonstrated durable single-dose protection against lethal Clade I mpox and other orthopoxviruses, potentially ...

Financial Services Virtual Investor Conference to Showcase Community Banks, Real Estate and Digital Assets
The September 24 virtual conference will feature live presentations and Q&A from five companies across community banking, wealth management, logistics...

Marygold Companies Narrows Loss as USCF Investments Shines, Pivots to Core Fund Management
The Marygold Companies reported an 8% revenue increase for fiscal 2026, narrowed its net loss to $4.4 million, and is restructuring to focus on its co...

Onco-Innovations Integrates Manufacturing and Preclinical Efforts for ONC010 Cancer Candidate
Onco-Innovations is advancing its lead preclinical cancer candidate ONC010 toward first-in-human testing by aligning manufacturing, formulation, and r...

VERAXA Biotech Appoints Capital Markets Veteran Raju Willener as CFO to Bolster Oncology Pipeline Advancement
VERAXA Biotech has named Raju Willener as its new chief financial officer, bringing over 30 years of international capital markets experience to help ...

Nano-X Imaging Builds End-to-End Platform to Transform Medical Imaging and Preventive Care
Nano-X Imaging's integrated platform combining digital X-ray, AI, and cloud services aims to expand access to preventive healthcare and improve early ...

Apimeds Engages IBN to Boost Visibility for Its Digital Asset and Biopharma Ventures
Apimeds Pharmaceuticals US (NYSE American: APUS) has hired IBN to handle its corporate communications, aiming to raise investor awareness for its subs...

Regentis Biomaterials CEO Highlights GelrinC's U.S. Pivotal Trial and European Commercialization in BioMedWire Podcast
Regentis Biomaterials CEO Dr. Ehud Geller discussed the company's lead product GelrinC, its U.S. pivotal trial and European commercialization, emphasi...

Silo Pharma Secures U.S. Patent Allowance for PTSD Therapeutic SPC-15
Silo Pharma receives a U.S. patent Notice of Allowance for its intranasal PTSD treatment SPC-15, strengthening its intellectual property portfolio and...

Goldman Sachs Predicts Another Fed Rate Hike in October, Impacting Key Sectors
Goldman Sachs now expects another Federal Reserve rate hike in October following the Fed's unanimous 25 basis point increase in September, a move that...

Study Links Bacterial Strains to Infection Risks from Air Pollution, Highlighting Need for Accessible Diagnostics
A new study reveals that individual bacterial strains in the microbiome affect the risk of sepsis, meningitis, and pneumonia from air pollution, while...

Nightfood Holdings Expands TechForce Robotics Platform into Pharmaceutical, Semiconductor, and Industrial Automation Markets
Nightfood Holdings is expanding its TechForce Robotics platform beyond hospitality into high-growth automation markets, including pharmaceutical, semi...

Hong Kong-Led GoGlobal Task Force Delegation to Canada to Boost Mainland Enterprises' Global Expansion
Invest Hong Kong leads a delegation of Mainland sustainability and life sciences companies to Canada to foster cross-border investment and partnership...

Peptide Wholesale Supply Expands HPLC Testing to Bulk Semaglutide and Tirzepatide Orders
Peptide Wholesale Supply now provides HPLC chromatographic data for every batch of BPC-157, Semaglutide, and Tirzepatide in bulk orders, enhancing tra...

Early Clinical Trial Conversations Crucial for Small Cell Lung Cancer Patients
Experts emphasize that asking about clinical trials at the first appointment can open doors to promising new treatments and improved quality of life f...

Regentis Biomaterials Advances GelrinC as Potential Game-Changer in Knee Cartilage Repair
Regentis Biomaterials is advancing GelrinC, an off-the-shelf hydrogel implant designed to regenerate knee cartilage, addressing a significant unmet ne...

ORGANA International Meets Retail Buyers at ECRM to Expand U.S. Retail Presence
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to expand its retail distribution...

Med-X Advances Nature-Cide Pest-Control Platform Ahead of Planned Nasdaq Listing
Med-X is expanding its Nature-Cide natural pest-control brand and has obtained OMRI certification for key products, positioning itself for growth as i...

Telomir-Zn Shows Growth Inhibition in Human and Canine Osteosarcoma Models
Telomir Pharmaceuticals reports that its lead candidate Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines, supporting further tr...

Quantum BioPharma's FDA Clearance for Lucid-MS IND Paves Way for Phase 2 Multiple Sclerosis Trial
Quantum BioPharma has received FDA clearance for its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial in multiple sclerosis...

GeoVax Partners with CEPI to Independently Validate MVA-Based Mpox Vaccine, Aiming to Diversify Global Supply
GeoVax's agreement with CEPI to use its Centralised Laboratory Network for the GEO-MVA Phase 3 trial aims to provide independent validation and suppor...

Aortic Stiffness May Drive Midlife Pulse Pressure Rise in Women, Not Menopause
New research from the Framingham Heart Study reveals that the midlife rise in pulse pressure and aortic stiffness in women begins decades before menop...

Dental Design Studios Expands to Nine Phoenix Offices, Boosting Access to Full Arch Implants and Emergency Care
Dental Design Studios has expanded its services to nine Phoenix-area locations, increasing access to full arch implants, cosmetic dentistry, and same-...

Engineered Suppressor tRNA Therapy Shows Promise for Duchenne Muscular Dystrophy
Tevard Biosciences and collaborators published preclinical research demonstrating that engineered suppressor tRNAs can restore full-length dystrophin ...

Translational Longevity: The Critical Bridge from Lab to Patient
The August Wellness Index Report emphasizes that translating longevity science into clinical practice is essential for real progress, highlighting key...

Creative Biolabs Expands Functionalized Lipid-Based Delivery Systems to Overcome Key Research Barriers
Creative Biolabs has expanded its functionalized lipid-based delivery system development capabilities, offering customized targeted and stimuli-respon...

Dr. Thanapoom Boonipat Scholarship for Future Doctors Offers $1,000 to Aspiring Physicians Nationwide
The Dr. Thanapoom Boonipat Scholarship for Future Doctors provides a $1,000 award to an undergraduate student committed to a career in medicine, with ...

LiverRight and Aegle Medical Solutions Partner to Expand Access to Liver Disease Detection and Care
LiverRight and Aegle Medical Solutions have formed a strategic partnership to combine advanced liver assessment technology with virtual specialist int...

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Solutions to Advance Biomedical Discovery
Creative Biolabs has upgraded its single-cell and single-nucleus RNA sequencing and multi-omics services to help researchers overcome sample processin...

Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
A comprehensive review reveals that the tumor microenvironment actively sculpts natural killer cells into distinct functional subsets, offering new av...

Nanox Expands Latin American Presence with Costa Rica Distribution Agreement for Nanox.ARC
Nanox's distribution agreement with SOLME RC for Costa Rica marks its third Latin American market this year, advancing the company's mission to expand...

Life Sciences Virtual Investor Forum to Showcase Seven Companies Advancing Cancer, Antibiotic, and Drug Delivery Innovations
The September 17 Life Sciences Virtual Investor Forum will feature live presentations and Q&A from seven companies developing therapies in oncology, f...


